Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Airway disease and inhaled corticosteroids (ICS) in children with primary ciliary dyskinesia (PCD)

Eleonora Dehlink, Charlotte Richardson, Gemma Marsh, Kiri Pares, Angela Jamalzadeh, Andy Bush, Claire Hogg, Siobhán B. Carr
European Respiratory Journal 2016 48: PA1601; DOI: 10.1183/13993003.congress-2016.PA1601
Eleonora Dehlink
1Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charlotte Richardson
1Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gemma Marsh
1Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kiri Pares
1Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angela Jamalzadeh
1Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andy Bush
1Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claire Hogg
1Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Siobhán B. Carr
1Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

PCD is characterized by neutrophilic airways disease, but despite the fact that many patients are prescribed ICS, the contribution of Type 2 inflammation is often not well characterized. We hypothesized that ICS are overprescribed in PCD.

We studied 103 children (46 girls) with confirmed PCD (age 9.9±4.4 years). Forty-eight patients (46.6%) were atopic based on elevated total IgE and/or specific IgE to common inhalant allergens. Thirty-eight patients (37%) were prescribed ICS. Patients who were and were not treated with ICS did not differ significantly in FEV1 (median [interquartile range] 82 [70.5-87.5] vs 85 [80-92] % pred), atopy (50% vs 43%), vitamin D levels (47 [32-57] vs 53 [34-66] nmol/l), extent of chest CT changes, and fractional exhaled nitric oxide (FeNO, 5 [5-8.‘5‘] vs 7.5 [5.3-12.5] pbb). Bronchodilator reversibility (BDR) >10% was found in 28% but was not associated with atopy (OR 2.13, 95%, 95% CI 0.5-8.5), FeNO (OR 0.9, 95%CI 0.1-7.7), or being treated with ICS (OR 2.1 95% CI 0.54-8.2). Those prescribed ICS showed slightly greater BDR (8 [6-14] vs 4 [1-10] %). Eosinophilia in broncho-alveolar lavage was rare (4/32), and almost exclusively seen in atopic patients. When comparing atopic and non-atopic PCD patients, atopic patients had significantly higher FeNO (median 10.5 [7.5-13] vs ‘5 [5-6.5] ‘ppb, p=0.008), but values above normal were not seen.

We conclude that atopy and BDR are common in children with PCD. ICS do not seem to be well targeted to children with Type 2 inflammation, FeNO is never above normal, implying sputum eosinophilia should be measured before prescribing ICS. Acute BDR of itself is not a sufficient reason for prescribing ICS.

  • Asthma - diagnosis
  • Bronchiectasis
  • Children
  • Copyright ©the authors 2016
Previous
Back to top
Vol 48 Issue suppl 60 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Airway disease and inhaled corticosteroids (ICS) in children with primary ciliary dyskinesia (PCD)
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Airway disease and inhaled corticosteroids (ICS) in children with primary ciliary dyskinesia (PCD)
Eleonora Dehlink, Charlotte Richardson, Gemma Marsh, Kiri Pares, Angela Jamalzadeh, Andy Bush, Claire Hogg, Siobhán B. Carr
European Respiratory Journal Sep 2016, 48 (suppl 60) PA1601; DOI: 10.1183/13993003.congress-2016.PA1601

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Airway disease and inhaled corticosteroids (ICS) in children with primary ciliary dyskinesia (PCD)
Eleonora Dehlink, Charlotte Richardson, Gemma Marsh, Kiri Pares, Angela Jamalzadeh, Andy Bush, Claire Hogg, Siobhán B. Carr
European Respiratory Journal Sep 2016, 48 (suppl 60) PA1601; DOI: 10.1183/13993003.congress-2016.PA1601
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Risk factors for intensive care and respiratory support among infants with bronchiolitis
  • Influence of single nucleotide polymorphisms in post-bronchiolitis wheezing
  • Blood gas analysis in acute bronchiolitis – Who and when?
Show more 7.4 Paediatric Respiratory Infection and Immunology

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society